Related Experiment Video
Updated: Jul 4, 2025

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
Published on: July 28, 2020
Extraplaque blood withdrawal stenting: A miraculous cure for subintimal hematoma
1Prince of Wales Hospital, Chinese University Hong Kong, Hong Kong.
A novel stenting technique, Extraplaque Blood Withdrawal, effectively manages extraplaque hematoma complications arising from chronic total occlusion percutaneous coronary intervention (CTO PCI). This method offers a new solution for challenging PCI procedures.
Area of Science:
- Cardiovascular Interventions
- Interventional Cardiology
- Vascular Surgery
Background:
- Chronic total occlusion percutaneous coronary intervention (CTO PCI) is a complex procedure.
- Extraplaque hematoma is a potential complication during CTO PCI.
- Managing extraplaque hematoma can be challenging and impact procedural success.
Purpose of the Study:
- To introduce and describe the Extraplaque Blood Withdrawal (EBW) stenting technique.
- To evaluate the efficacy of the EBW technique in treating CTO PCI-induced extraplaque hematoma.
- To provide a potential solution for managing this specific complication.
Main Methods:
- The Extraplaque Blood Withdrawal stenting technique involves specific procedural steps.
- The technique aims to aspirate or manage hematoma outside the true lumen.
- Case report or series detailing the application of the EBW technique.
Main Results:
- The EBW technique was successfully applied to treat extraplaque hematoma.
- The technique facilitated successful stenting in cases of CTO PCI-induced hematoma.
- Procedural outcomes and safety of the EBW technique were observed.
Conclusions:
- The Extraplaque Blood Withdrawal stenting technique is a viable option for managing CTO PCI-induced extraplaque hematoma.
- This technique may improve outcomes in complex CTO PCI procedures.
- Further studies are warranted to confirm the utility and long-term efficacy of the EBW technique.
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Vascular Spasm
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

